Anti-XPC antibody

Anti-XPC antibody

Catalog Number:
A001017406STJ
Mfr. No.:
STJ110652
Price:
$297
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • This gene encodes a component of the nucleotide excision repair (NER) pathway. There are multiple components involved in the NER pathway, including Xeroderma pigmentosum (XP) A-G and V, Cockayne syndrome (CS) A and B, and trichothiodystrophy (TTD) group A, etc. This component, XPC, plays an important role in the early steps of global genome NER, especially in damage recognition, open complex formation, and repair protein complex formation. Mutations in this gene or some other NER components result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene.

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human
          Immunogen
          Recombinant fusion protein containing a sequence corresponding to amino acids 700-940 of human XPC (NP_004619. 3).
          Purification
          Affinity purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
          Storage
          Store at -20°C and avoid freeze-thaw cycles.
          Regulatory Status
          RUO
          Antigen
          Dna Repair Protein Complementing Xp-C Cells; Xeroderma Pigmentosum Group C-Complementing Protein; P125 (Gene ID:7508; UniProt:Q01831)

          * For research use only

      • Applications
        • Application
          WB; IHC
        • Application Dilutions
          WB 1:500-1:2000
          IHC 1:50-1:100

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.